J.P. Morgan Healthcare Conference begins on Monday

By Admin
This week, thousands of the top health executives and investors around the globe will attend the four-day J.P. Morgan Healthcare Conference at the Westi...

This week, thousands of the top health executives and investors around the globe will attend the four-day J.P. Morgan Healthcare Conference at the Westin St. Francis in San Francisco.

The 34th annual conference is expected to bring in over 9,000 people, with some of the biggest names in the pharmaceutical sector in attendance. In addition, the conference primarily based in Union Square will include major hospitals, insurers, biotech firms and health care services companies.

RELATED TOPIC: Billionaire firm NantHealth to become IPO with Allscripts investment

It is the largest and oldest health investment conference in the industry, which continues to be the life science industry’s most popular event of the year. It also includes a two-day StartUp Health Festival where entrepreneurs attempt to connect with investors, customers and potential business partners.

Among the top topics this year is digital health, which has attracted interest. Investors put over $4.3 billion into digital health last year alone, which is a significant increase from the $1.1 billion in funding in 2011.

RELATED TOPIC: Is mHealth worth your venture capital investment?

“You’ve got thousands of investors coming into San Francisco for this J.P. Morgan conference, the biggest concentration of money in health care,” said StartUp Health co-founder Unity Stoakes. “We’ve never even been invited to the J.P. Morgan conference, so we decided to create our own festival at the gates of the conference.”

Let's connect!   

Click here to read the latest edition of Healthcare Global magazine!

Share

Featured Articles

The Merck Group: Pharma's History & Innovation in India

Welcome back to part two of our exploration of The Merck Group's history and investment in China and India, with this part focusing on innovation in India

How CVS Health is Rising to the Omnichannel Challenge

US healthcare company CVS Health is reshaping its supply chain to meet the omnichannel needs of its customers

Kinaxis: Pharma Seeing Euro-wide Supply Chain Challenges

Supply chain specialist Kinaxis says UK pharma still recovering from Brexit and pandemic, and that Europe also seeing medicines value chain problems

Healthcare Digital Transformations Stymied by Data Silos

Digital Healthcare

McKinsey: Brain Health Underfunding 'a Global Concern'

Digital Healthcare

Endometriosis Linked to Heart Attacks & Strokes

Medical Devices & Pharma